Perrigo Paying $309M To Settle $1.9Bn Irish Tax Assessment From Elan Merger

OTC private label/store brand giant announces Irish authorities allow it to pay $308.7m to settle a $1.9bn assessment for back taxes ordered in 2018 linked to Rx ingredient royalty rights it gained in its 2103 merger with Elan.

• Source: Alamy

There’s a reason Perrigo Company PLC’s share price increased nearly 12% in after-hours trading on 29 September – nearly 309 million reasons, actually.

The OTC private label and store brand giant announced after the markets closed that Irish authorities agreed to let it pay €266.1m ($308.7m) to settle a €1.6bn ($1

The news spurred after-hours trading in Perrigo’s shares that pushed the price up 11.49% from a close of $43.50 to $48.50 by 8 p.m. EDT

More from Deals

More from Business